Global Pulmonary Fibrosis Biomarkers Market Size To Exceed USD 6.1 Billion By 2033 | CAGR of 4.3%
12 avr. 2024 09h00 HE
|
SPHERICAL INSIGHTS LLP
New York, United States , April 12, 2024 (GLOBE NEWSWIRE) -- The Global Pulmonary Fibrosis Biomarkers Market Size is to Grow from USD 4.0 Billion in 2023 to USD 6.1 Billion by 2033, at a Compound...
Global Idiopathic Pulmonary Fibrosis (IPF) Market Report 2024-2034: IPF Industry to Observe Robust Expansion with Emerging Therapies and Increasing Prevalence of Cough-Related IPF
25 janv. 2024 07h29 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Cough in Idiopathic pulmonary fibrosis (IPF) - Market Insights, Epidemiology, and Market Forecast - 2034" report has been added to ...
Global Idiopathic Pulmonary Fibrosis (IPF) Market to 2029: Players Include Boehringer Ingelheim, F. Hoffmann-La Roche, Cipla and Shionogi & Co
13 juil. 2023 04h33 HE
|
Research and Markets
Dublin, July 13, 2023 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis (IPF) Market (2023 Edition): Analysis By Drug Type (Pirfenidone, Nintedanib, Others), Route of Administration...
Global Idiopathic Pulmonary Fibrosis Market Report 2023: Sector is Expected to Reach $7.52 Billion by 2030 at a CAGR of 8.7%
15 juin 2023 08h03 HE
|
Research and Markets
Dublin, June 15, 2023 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Market, By Drug, By Route of Administration, By Distribution Channel, and By Geography - Size, Share, Outlook, and...
Europe Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, Shionogi & Co, AstraZeneca & Others
11 août 2022 05h03 HE
|
Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Europe Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies,...
LAMEA Idiopathic Pulmonary Fibrosis Market Report 2022: Featuring Key Players GNI Group, AstraZeneca, Bristol Myers Squibb & Others
04 août 2022 04h38 HE
|
Research and Markets
Dublin, Aug. 04, 2022 (GLOBE NEWSWIRE) -- The "LAMEA Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail Pharmacies,...
APAC Idiopathic Pulmonary Fibrosis Market to 2027 - Size, Share & Industry Trends Analysis Report
19 mai 2022 05h03 HE
|
Research and Markets
Dublin, May 19, 2022 (GLOBE NEWSWIRE) -- The "Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail...
The Worldwide Idiopathic Pulmonary Fibrosis Industry is Expected to Reach $4.7 Billion by 2027
25 avr. 2022 07h08 HE
|
Research and Markets
Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis Market Size, Share & Industry Trends Analysis Report By Drug Type, By Distribution Channel (Retail...
The Worldwide Idiopathic Pulmonary Fibrosis Industry is Projected to Reach $6 Billion by 2030
31 mars 2022 06h13 HE
|
Research and Markets
Dublin, March 31, 2022 (GLOBE NEWSWIRE) -- The "Idiopathic Pulmonary Fibrosis Market by Drug Type and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has...
Global Idiopathic Pulmonary Fibrosis (IPF) Industry Forecast, 2030 - Competitive Landscape Assessment, Product Development & Innovation, Case Reports, Marketed Products & Emerging Therapies
28 févr. 2022 06h23 HE
|
Research and Markets
Dublin, Feb. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Idiopathic Pulmonary Fibrosis Market, By Therapy, Estimation & Forecast, 2017-2030" report has been added to ResearchAndMarkets.com's...